BioCryst Pharmaceuticals Inc
BCRXHealthcare|Drug Manufacturers - Specialty & Generic|USA
$10.45
-0.27 (-2.52%)
Upcoming Data Readouts (2)
Oct 2026
Est. completion
P1Netherton Syndrome
A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725
NCT06539507n=78
Dec 2026
Est. completion
P3Hereditary Angioedema (HAE)
A Study of Navenibart in Participants With Hereditary Angioedema
NCT06842823n=157
Awaiting Results (1)
Trials past primary completion date but still active — data readout may be imminent.